Table 3 Baseline levels of the measured markers according to different clinical conditions

Age > median (62 years)

+

110 (88, 137)

519 (455, 581)

1.00 (0.79, 1.15)

0.21 (0.17, 0.29)

117 (86, 170)

–

100 (79, 127)

547 (467, 627)

1.05 (0.90, 1.21)

0.19 (0.14, 0.25)

97 (70, 136)

p

< 0.001

< 0.001

< 0.001

< 0.001

< 0.001

Sex (female)

+

106 (82, 136)

549 (463, 622)

1.04 (0.84, 1.19)

0.20 (0.14, 0.26)

111 (76, 157)

–

106 (83, 133)

525 (460, 596)

1.02 (0.82, 1.19)

0.20 (0.15, 0.27)

106 (77, 150)

p

0.840

0.052

0.877

0.611

0.726

Diabetes

+

111 (83, 141)

557 (465, 639)

1.05 (0.81, 1.18)

0.20 (0.15, 0.27)

117 (84, 170)

–

105 (83, 131)

524 (459, 596)

1.02 (0.83, 1.19)

0.20 (0.15, 0.26)

106 (76, 147)

p

0.023

0.003

0.931

0.602

0.059

Hypertension

+

104 (80, 132)

530 (463, 606)

1.01 (0.79, 1.16)

0.20 (0.15, 0.26)

107 (76, 150)

–

108 (86, 134)

533 (458, 607)

1.05 (0.86, 1.21)

0.20 (0.16, 0.28)

106 (77, 153)

p

0.033

0.959

0.034

0.081

0.962

Previous CVD

+

110 (86, 137)

534 (463, 608)

1.02 (0.82, 1.19)

0.20 (0.16, 0.27)

110 (82, 160)

–

98 (78, 126)

525 (456, 602)

1.04 (0.85, 1.18)

0.19 (0.14, 0.25)

103 (72, 136)

p

< 0.001

0.453

0.663

0.001

0.002

Smokers

+

107 (88, 134)

520 (441, 590)

1.03 (0.86, 1.19)

0.20 (0.16, 0.28)

108 (78, 151)

–

105 (83, 133)

532 (466, 607)

1.02 (0.82, 1.18)

0.20 (0.15, 0.26)

107 (77, 152)

p

0.621

0.100

0.306

0.515

0.796